+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Critical Care Adsorption Solutions Market by Product Type, Application, End User, Technology, Adsorbent Material, Patient Type - Global Forecast to 2030- Product Image
Critical Care Adsorption Solutions Market by Product Type, Application, End User, Technology, Adsorbent Material, Patient Type - Global Forecast to 2030- Product Image
Sale

Critical Care Adsorption Solutions Market by Product Type, Application, End User, Technology, Adsorbent Material, Patient Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6078995
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Critical care adsorption solutions are transforming patient management in intensive care settings, enabling healthcare providers to address sepsis, cytokine storms, and drug toxicity more effectively through advanced blood purification technologies. Senior decision-makers evaluating market-entry or expansion strategies require a clear understanding of evolving clinical needs, technological advances, and regional adoption trends in this rapidly growing sector.

Market Snapshot: Critical Care Adsorption Solutions

The critical care adsorption market is experiencing robust growth due to increasing awareness of the role of hemofiltration and adsorption devices in managing acute clinical conditions. Strong demand is observed for advanced solutions capable of removing circulating toxins, drug residues, and inflammatory mediators. As critical care units confront the challenges posed by sepsis, drug overdose, and complications from immunotherapies, solutions such as hemoperfusion cartridges and plasma adsorption columns are being rapidly adopted to enhance patient outcomes and streamline intensive care workflows.

Scope & Segmentation

This report provides a comprehensive analysis of the critical care adsorption market, covering product types, clinical applications, end users, enabling technologies, core materials, and patient demographics. Market coverage spans the Americas, Europe, the Middle East & Africa, and Asia-Pacific, reflecting dynamic regulatory and procurement landscapes.

  • Product Type: Hemofiltration adsorbers, hemoperfusion cartridges, and plasma adsorption columns with features such as regenerative filters, synthetic filters, continuous and intermittent flow modalities, Cytosorb and Polymyxin B cartridges.
  • Application: Interventions targeting cytokine storms in CAR-T therapy and viral infections, management of drug overdoses (acetaminophen, opioids), acute and chronic liver failure, and broad-spectrum sepsis care for gram-negative and gram-positive pathogens.
  • End User: Hospitals (teaching and non-teaching), dedicated clinics, and research institutes deploying both established and investigational protocols.
  • Technology: Extracorporeal and intravascular platforms in continuous and intermittent operation, central and peripheral access systems, and integrated compatibility with renal replacement and ECMO therapies.
  • Adsorbent Material: Activated carbon (granular, powdered), synthetic polymers (polymethyl methacrylate, styrene divinylbenzene), natural zeolites (clinoptilolite, mordenite).
  • Patient Type: Adult, neonatal (full term, preterm), and pediatric (infant, toddler) populations with specialized requirements for device sizing and biocompatibility.
  • Region: Americas (including United States, Canada, Brazil, Mexico, Argentina), Europe, Middle East & Africa (major EU economies, GCC nations, South Africa), Asia-Pacific (China, India, Japan, Australia, Southeast Asia). [ImageId=GUID]
  • Key Players Included: CytoSorbents Corporation, Toray Industries, Jafron Biomedical, Baxter International, Fresenius Medical Care, Asahi Kasei Medical, B. Braun Melsungen, Medtronic plc, Nikkiso Co., Nipro Corporation.

Key Takeaways: Strategic Insights for Decision-Makers

  • Rapid advances in material science underpin a new generation of adsorption devices, with synthetic polymers and zeolites enhancing selectivity and efficiency.
  • Integration of digital platforms and real-time analytics allows clinicians to optimize device settings, supporting evidence-based therapy customization.
  • Global regulators are accelerating pathways for approval of innovative adsorption technologies, creating early-mover advantages for companies with robust clinical data.
  • Partnerships between device manufacturers and academic research centers are expediting translation of novel chemistries into bedside tools, fostering a dynamic R&D environment.
  • Regional variations in reimbursement models and procurement policies create nuanced barriers and opportunities for market entry and expansion across key geographies.

Tariff Impact on Critical Care Adsorption Solutions

United States tariffs effective in 2025 on medical devices and input materials have introduced margin pressures, prompting manufacturers to review sourcing, negotiate new contracts, and consider relocating production closer to end-user markets. Some vendors are adopting alternative adsorbent materials to minimize tariff costs, while hospitals seek transparent breakdowns and bundled service options to offset cost fluctuations. Localization and lean manufacturing are emerging as strategic responses, driving supply chain resilience and operational efficiency.

Methodology & Data Sources

This analysis combines a multi-phase methodology, including secondary research from peer-reviewed journals and regulatory filings, proprietary data tracking on product launches and patent activity, and primary interviews with clinicians, procurement professionals, and material scientists in key markets. Data triangulation and expert panel validation ensure robust segmentation, while quantitative models account for regulatory shifts and adoption rates.

Why This Report Matters

  • Enables C-suite leaders to anticipate market shifts driven by clinical needs, innovation cycles, and evolving regulatory frameworks.
  • Provides actionable recommendations for investment prioritization and partnership development in both established and emerging healthcare markets.
  • Equips strategic planners with a granular view of segmentation, enabling more tailored and responsive go-to-market strategies.

Conclusion

This report delivers a clear, actionable framework for engaging the critical care adsorption market. Leaders can leverage these insights to optimize portfolios, align with clinical priorities, and drive sustainable growth in a rapidly evolving therapeutic environment.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Critical Care Adsorption Solutions Market, by Product Type
8.1. Introduction
8.2. Hemofiltration Adsorber
8.2.1. Regenerative Filter
8.2.2. Synthetic Filter
8.3. Hemoperfusion Cartridge
8.3.1. Continuous Flow
8.3.2. Intermittent Flow
8.4. Plasma Adsorption Column
8.4.1. Cytosorb Cartridge
8.4.2. Polymyxin B Column
9. Critical Care Adsorption Solutions Market, by Application
9.1. Introduction
9.2. Cytokine Storm
9.2.1. CAR-T Therapy
9.2.2. COVID-19
9.3. Drug Overdose
9.3.1. Acetaminophen
9.3.2. Opioid
9.4. Liver Failure
9.4.1. Acute
9.4.2. Chronic
9.5. Sepsis
9.5.1. Gram Negative
9.5.2. Gram Positive
10. Critical Care Adsorption Solutions Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Hospitals
10.3.1. Non-Teaching
10.3.2. Teaching
10.4. Research Institutes
11. Critical Care Adsorption Solutions Market, by Technology
11.1. Introduction
11.2. Extracorporeal
11.2.1. Continuous
11.2.2. Intermittent
11.3. Intravascular
11.3.1. Central
11.3.2. Peripheral
12. Critical Care Adsorption Solutions Market, by Adsorbent Material
12.1. Introduction
12.2. Activated Carbon
12.2.1. Granular
12.2.2. Powdered
12.3. Synthetic Polymer
12.3.1. Polymethyl Methacrylate
12.3.2. Styrene Divinylbenzene
12.4. Zeolites
12.4.1. Clinoptilolite
12.4.2. Mordenite
13. Critical Care Adsorption Solutions Market, by Patient Type
13.1. Introduction
13.2. Adult
13.3. Neonatal
13.3.1. Full Term
13.3.2. Preterm
13.4. Pediatric
13.4.1. Infant
13.4.2. Toddler
14. Americas Critical Care Adsorption Solutions Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Critical Care Adsorption Solutions Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Critical Care Adsorption Solutions Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. CytoSorbents Corporation
17.3.2. Toray Industries, Inc.
17.3.3. Jafron Biomedical Co., Ltd.
17.3.4. Baxter International, Inc.
17.3.5. Fresenius Medical Care AG & Co. KGaA
17.3.6. Asahi Kasei Medical Co., Ltd.
17.3.7. B. Braun Melsungen AG
17.3.8. Medtronic plc
17.3.9. Nikkiso Co., Ltd.
17.3.10. Nipro Corporation
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CRITICAL CARE ADSORPTION SOLUTIONS MARKET MULTI-CURRENCY
FIGURE 2. CRITICAL CARE ADSORPTION SOLUTIONS MARKET MULTI-LANGUAGE
FIGURE 3. CRITICAL CARE ADSORPTION SOLUTIONS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CRITICAL CARE ADSORPTION SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CRITICAL CARE ADSORPTION SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CRITICAL CARE ADSORPTION SOLUTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY REGENERATIVE FILTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC FILTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTERMITTENT FLOW, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOSORB CARTRIDGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYMYXIN B COLUMN, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CAR-T THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COVID-19, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY OPIOID, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CHRONIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GRAM NEGATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GRAM POSITIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NON-TEACHING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TEACHING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTERMITTENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CENTRAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY GRANULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POWDERED, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY POLYMETHYL METHACRYLATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY STYRENE DIVINYLBENZENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CLINOPTILOLITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY MORDENITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY FULL TERM, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRETERM, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INFANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TODDLER, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 119. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2030 (USD MILLION)
TABLE 121. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2030 (USD MILLION)
TABLE 122. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2030 (USD MILLION)
TABLE 123. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2018-2030 (USD MILLION)
TABLE 125. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2018-2030 (USD MILLION)
TABLE 126. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2018-2030 (USD MILLION)
TABLE 127. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 128. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 130. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2018-2030 (USD MILLION)
TABLE 132. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2018-2030 (USD MILLION)
TABLE 133. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2018-2030 (USD MILLION)
TABLE 134. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2018-2030 (USD MILLION)
TABLE 135. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2030 (USD MILLION)
TABLE 136. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2018-2030 (USD MILLION)
TABLE 137. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 138. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2018-2030 (USD MILLION)
TABLE 139. CANADA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 140. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2030 (USD MILLION)
TABLE 142. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2030 (USD MILLION)
TABLE 143. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2030 (USD MILLION)
TABLE 144. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2018-2030 (USD MILLION)
TABLE 146. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2018-2030 (USD MILLION)
TABLE 147. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2018-2030 (USD MILLION)
TABLE 148. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 149. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 151. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2018-2030 (USD MILLION)
TABLE 153. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2018-2030 (USD MILLION)
TABLE 154. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2018-2030 (USD MILLION)
TABLE 155. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2018-2030 (USD MILLION)
TABLE 156. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2030 (USD MILLION)
TABLE 157. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2018-2030 (USD MILLION)
TABLE 158. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 159. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2018-2030 (USD MILLION)
TABLE 160. MEXICO CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 182. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2030 (USD MILLION)
TABLE 184. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2030 (USD MILLION)
TABLE 185. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2030 (USD MILLION)
TABLE 186. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2018-2030 (USD MILLION)
TABLE 188. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2018-2030 (USD MILLION)
TABLE 189. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2018-2030 (USD MILLION)
TABLE 190. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 191. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 193. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2018-2030 (USD MILLION)
TABLE 195. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2018-2030 (USD MILLION)
TABLE 196. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2018-2030 (USD MILLION)
TABLE 197. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2018-2030 (USD MILLION)
TABLE 198. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2030 (USD MILLION)
TABLE 199. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2018-2030 (USD MILLION)
TABLE 200. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 201. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2018-2030 (USD MILLION)
TABLE 202. ARGENTINA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2030 (USD MILLION)
TABLE 242. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2018-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 244. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2018-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 246. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2030 (USD MILLION)
TABLE 248. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2030 (USD MILLION)
TABLE 249. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2030 (USD MILLION)
TABLE 250. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2018-2030 (USD MILLION)
TABLE 252. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2018-2030 (USD MILLION)
TABLE 253. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2018-2030 (USD MILLION)
TABLE 254. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 255. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 257. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2018-2030 (USD MILLION)
TABLE 259. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2018-2030 (USD MILLION)
TABLE 260. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2018-2030 (USD MILLION)
TABLE 261. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2018-2030 (USD MILLION)
TABLE 262. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2030 (USD MILLION)
TABLE 263. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2018-2030 (USD MILLION)
TABLE 264. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 265. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2018-2030 (USD MILLION)
TABLE 266. GERMANY CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 267. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2030 (USD MILLION)
TABLE 269. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2030 (USD MILLION)
TABLE 270. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2030 (USD MILLION)
TABLE 271. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY CYTOKINE STORM, 2018-2030 (USD MILLION)
TABLE 273. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY DRUG OVERDOSE, 2018-2030 (USD MILLION)
TABLE 274. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY LIVER FAILURE, 2018-2030 (USD MILLION)
TABLE 275. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SEPSIS, 2018-2030 (USD MILLION)
TABLE 276. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 278. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY EXTRACORPOREAL, 2018-2030 (USD MILLION)
TABLE 280. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY INTRAVASCULAR, 2018-2030 (USD MILLION)
TABLE 281. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ADSORBENT MATERIAL, 2018-2030 (USD MILLION)
TABLE 282. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ACTIVATED CARBON, 2018-2030 (USD MILLION)
TABLE 283. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY SYNTHETIC POLYMER, 2018-2030 (USD MILLION)
TABLE 284. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY ZEOLITES, 2018-2030 (USD MILLION)
TABLE 285. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 286. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY NEONATAL, 2018-2030 (USD MILLION)
TABLE 287. FRANCE CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PEDIATRIC, 2018-2030 (USD MILLION)
TABLE 288. RUSSIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 289. RUSSIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOFILTRATION ADSORBER, 2018-2030 (USD MILLION)
TABLE 290. RUSSIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY HEMOPERFUSION CARTRIDGE, 2018-2030 (USD MILLION)
TABLE 291. RUSSIA CRITICAL CARE ADSORPTION SOLUTIONS MARKET SIZE, BY PLASMA ADSORPTION COLUMN, 2018-2030 (USD MILLION)
TABLE 292. RUSSIA CRITICAL C

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Critical Care Adsorption Solutions market report include:
  • CytoSorbents Corporation
  • Toray Industries, Inc.
  • Jafron Biomedical Co., Ltd.
  • Baxter International, Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Medtronic plc
  • Nikkiso Co., Ltd.
  • Nipro Corporation

Related Topics

Related Reports

Zeolite Rotary Adsorption NMP Recovery System Market by Adsorbent Type, Application, End User, System Capacity, Sales Channel - Global Forecast to 2030 - Product Image

Zeolite Rotary Adsorption NMP Recovery System Market by Adsorbent Type, Application, End User, System Capacity, Sales Channel - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Adsorption Equipment Market by Application, Adsorbent Type, Technology, Process, End-User Industry - Global Forecast to 2030 - Product Image

Adsorption Equipment Market by Application, Adsorbent Type, Technology, Process, End-User Industry - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Polymeric Adsorbent Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Polymeric Adsorbent Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
4A Molecular Sieve Adsorbent Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

4A Molecular Sieve Adsorbent Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
2025 Adsorbents Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032 - Product Image

2025 Adsorbents Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032

  • Report
  • 152 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.